Loading…
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity
Saved in:
| Published in: | British journal of haematology 2018-05, Vol.181 (3), p.413-417 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3884-4ddc09b5f73cf51ef0513f25d3cc06867e4a23b1d18aeb25a4950b47070e0b653 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3884-4ddc09b5f73cf51ef0513f25d3cc06867e4a23b1d18aeb25a4950b47070e0b653 |
| container_end_page | 417 |
| container_issue | 3 |
| container_start_page | 413 |
| container_title | British journal of haematology |
| container_volume | 181 |
| creator | Lohse, Stefan Loew, Sebastian Kretschmer, Anna Jansen, J. H. Marco Meyer, Saskia ten Broeke, Toine Rösner, Thies Dechant, Michael Derer, Stefanie Klausz, Katja Kellner, Christian Schwanbeck, Ralf French, Ruth R. Tipton, Thomas R. W. Cragg, Mark S. Schewe, Denis M. Peipp, Matthias Leusen, Jeanette H. W. Valerius, Thomas |
| description | |
| doi_str_mv | 10.1111/bjh.14624 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1893551691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1893551691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3884-4ddc09b5f73cf51ef0513f25d3cc06867e4a23b1d18aeb25a4950b47070e0b653</originalsourceid><addsrcrecordid>eNp1kUtuFDEQhi1ERIbAggsgS2xg0Ymf_Vgmk0ASRWIDa8ttlxOPuttD2y3oHUfIZbgQJ8HNTBBBwhtL5a8-VflH6BUlxzSfk3Zzd0xFycQTtKK8lAWjgj5FK0JIVVAi6kP0PMYNIZQTSZ-hQ1YL0XDRrNCPC-fApDDiHsydHnzsIw4OX92eYj0k3wbrIWJ9q_0QE16fM4L9YLrJAh7BjJNPPQxpaeln6IK32EDXReyyci-Yf36_t7CFwS7k8pwLPVivE2R8TiGFb974NOeOXAj9toPF-rjvL-4FOnC6i_Byfx-hz-8vPq0vi5uPH67WpzeF4XUtCmGtIU0rXcWNkxRc3p47Ji03hpR1WYHQjLfU0lpDy6QWjSStqEhFgLSl5Efo7c67HcOXCWJSvY_LAnqAMEVF64ZLScuGZvTNP-gmTOOQp1OMcEJrJlmdqXc7yowhxhGc2o6-1-OsKFFLlipnqX5nmdnXe-PU5t_6Qz6El4GTHfDVdzD_36TOri93yl8RZ68G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2030182528</pqid></control><display><type>article</type><title>Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Lohse, Stefan ; Loew, Sebastian ; Kretschmer, Anna ; Jansen, J. H. Marco ; Meyer, Saskia ; ten Broeke, Toine ; Rösner, Thies ; Dechant, Michael ; Derer, Stefanie ; Klausz, Katja ; Kellner, Christian ; Schwanbeck, Ralf ; French, Ruth R. ; Tipton, Thomas R. W. ; Cragg, Mark S. ; Schewe, Denis M. ; Peipp, Matthias ; Leusen, Jeanette H. W. ; Valerius, Thomas</creator><creatorcontrib>Lohse, Stefan ; Loew, Sebastian ; Kretschmer, Anna ; Jansen, J. H. Marco ; Meyer, Saskia ; ten Broeke, Toine ; Rösner, Thies ; Dechant, Michael ; Derer, Stefanie ; Klausz, Katja ; Kellner, Christian ; Schwanbeck, Ralf ; French, Ruth R. ; Tipton, Thomas R. W. ; Cragg, Mark S. ; Schewe, Denis M. ; Peipp, Matthias ; Leusen, Jeanette H. W. ; Valerius, Thomas</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.14624</identifier><identifier>PMID: 28449349</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>ADCC ; Animals ; antibody therapy ; Antibody-Dependent Cell Cytotoxicity - drug effects ; Antigens, CD20 - immunology ; Antineoplastic Agents, Immunological - immunology ; Antineoplastic Agents, Immunological - pharmacology ; CD20 ; CD20 antigen ; CHO Cells ; Complement System Proteins - immunology ; Cricetulus ; Cytotoxicity ; Hematology ; Humans ; IgA antibody ; Immunoglobulin A ; Immunoglobulin A - immunology ; Immunoglobulin A - pharmacology ; Leukemia, Prolymphocytic, B-Cell - drug therapy ; Leukemia, Prolymphocytic, B-Cell - immunology ; Leukemia, Prolymphocytic, B-Cell - pathology ; Myeloid cells ; Myeloid Cells - immunology ; Myeloid Cells - pathology ; myeloid effector cells</subject><ispartof>British journal of haematology, 2018-05, Vol.181 (3), p.413-417</ispartof><rights>2017 John Wiley & Sons Ltd</rights><rights>Copyright © 2018 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3884-4ddc09b5f73cf51ef0513f25d3cc06867e4a23b1d18aeb25a4950b47070e0b653</citedby><cites>FETCH-LOGICAL-c3884-4ddc09b5f73cf51ef0513f25d3cc06867e4a23b1d18aeb25a4950b47070e0b653</cites><orcidid>0000-0003-0777-5995</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28449349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lohse, Stefan</creatorcontrib><creatorcontrib>Loew, Sebastian</creatorcontrib><creatorcontrib>Kretschmer, Anna</creatorcontrib><creatorcontrib>Jansen, J. H. Marco</creatorcontrib><creatorcontrib>Meyer, Saskia</creatorcontrib><creatorcontrib>ten Broeke, Toine</creatorcontrib><creatorcontrib>Rösner, Thies</creatorcontrib><creatorcontrib>Dechant, Michael</creatorcontrib><creatorcontrib>Derer, Stefanie</creatorcontrib><creatorcontrib>Klausz, Katja</creatorcontrib><creatorcontrib>Kellner, Christian</creatorcontrib><creatorcontrib>Schwanbeck, Ralf</creatorcontrib><creatorcontrib>French, Ruth R.</creatorcontrib><creatorcontrib>Tipton, Thomas R. W.</creatorcontrib><creatorcontrib>Cragg, Mark S.</creatorcontrib><creatorcontrib>Schewe, Denis M.</creatorcontrib><creatorcontrib>Peipp, Matthias</creatorcontrib><creatorcontrib>Leusen, Jeanette H. W.</creatorcontrib><creatorcontrib>Valerius, Thomas</creatorcontrib><title>Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>ADCC</subject><subject>Animals</subject><subject>antibody therapy</subject><subject>Antibody-Dependent Cell Cytotoxicity - drug effects</subject><subject>Antigens, CD20 - immunology</subject><subject>Antineoplastic Agents, Immunological - immunology</subject><subject>Antineoplastic Agents, Immunological - pharmacology</subject><subject>CD20</subject><subject>CD20 antigen</subject><subject>CHO Cells</subject><subject>Complement System Proteins - immunology</subject><subject>Cricetulus</subject><subject>Cytotoxicity</subject><subject>Hematology</subject><subject>Humans</subject><subject>IgA antibody</subject><subject>Immunoglobulin A</subject><subject>Immunoglobulin A - immunology</subject><subject>Immunoglobulin A - pharmacology</subject><subject>Leukemia, Prolymphocytic, B-Cell - drug therapy</subject><subject>Leukemia, Prolymphocytic, B-Cell - immunology</subject><subject>Leukemia, Prolymphocytic, B-Cell - pathology</subject><subject>Myeloid cells</subject><subject>Myeloid Cells - immunology</subject><subject>Myeloid Cells - pathology</subject><subject>myeloid effector cells</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kUtuFDEQhi1ERIbAggsgS2xg0Ymf_Vgmk0ASRWIDa8ttlxOPuttD2y3oHUfIZbgQJ8HNTBBBwhtL5a8-VflH6BUlxzSfk3Zzd0xFycQTtKK8lAWjgj5FK0JIVVAi6kP0PMYNIZQTSZ-hQ1YL0XDRrNCPC-fApDDiHsydHnzsIw4OX92eYj0k3wbrIWJ9q_0QE16fM4L9YLrJAh7BjJNPPQxpaeln6IK32EDXReyyci-Yf36_t7CFwS7k8pwLPVivE2R8TiGFb974NOeOXAj9toPF-rjvL-4FOnC6i_Byfx-hz-8vPq0vi5uPH67WpzeF4XUtCmGtIU0rXcWNkxRc3p47Ji03hpR1WYHQjLfU0lpDy6QWjSStqEhFgLSl5Efo7c67HcOXCWJSvY_LAnqAMEVF64ZLScuGZvTNP-gmTOOQp1OMcEJrJlmdqXc7yowhxhGc2o6-1-OsKFFLlipnqX5nmdnXe-PU5t_6Qz6El4GTHfDVdzD_36TOri93yl8RZ68G</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Lohse, Stefan</creator><creator>Loew, Sebastian</creator><creator>Kretschmer, Anna</creator><creator>Jansen, J. H. Marco</creator><creator>Meyer, Saskia</creator><creator>ten Broeke, Toine</creator><creator>Rösner, Thies</creator><creator>Dechant, Michael</creator><creator>Derer, Stefanie</creator><creator>Klausz, Katja</creator><creator>Kellner, Christian</creator><creator>Schwanbeck, Ralf</creator><creator>French, Ruth R.</creator><creator>Tipton, Thomas R. W.</creator><creator>Cragg, Mark S.</creator><creator>Schewe, Denis M.</creator><creator>Peipp, Matthias</creator><creator>Leusen, Jeanette H. W.</creator><creator>Valerius, Thomas</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0777-5995</orcidid></search><sort><creationdate>201805</creationdate><title>Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity</title><author>Lohse, Stefan ; Loew, Sebastian ; Kretschmer, Anna ; Jansen, J. H. Marco ; Meyer, Saskia ; ten Broeke, Toine ; Rösner, Thies ; Dechant, Michael ; Derer, Stefanie ; Klausz, Katja ; Kellner, Christian ; Schwanbeck, Ralf ; French, Ruth R. ; Tipton, Thomas R. W. ; Cragg, Mark S. ; Schewe, Denis M. ; Peipp, Matthias ; Leusen, Jeanette H. W. ; Valerius, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3884-4ddc09b5f73cf51ef0513f25d3cc06867e4a23b1d18aeb25a4950b47070e0b653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>ADCC</topic><topic>Animals</topic><topic>antibody therapy</topic><topic>Antibody-Dependent Cell Cytotoxicity - drug effects</topic><topic>Antigens, CD20 - immunology</topic><topic>Antineoplastic Agents, Immunological - immunology</topic><topic>Antineoplastic Agents, Immunological - pharmacology</topic><topic>CD20</topic><topic>CD20 antigen</topic><topic>CHO Cells</topic><topic>Complement System Proteins - immunology</topic><topic>Cricetulus</topic><topic>Cytotoxicity</topic><topic>Hematology</topic><topic>Humans</topic><topic>IgA antibody</topic><topic>Immunoglobulin A</topic><topic>Immunoglobulin A - immunology</topic><topic>Immunoglobulin A - pharmacology</topic><topic>Leukemia, Prolymphocytic, B-Cell - drug therapy</topic><topic>Leukemia, Prolymphocytic, B-Cell - immunology</topic><topic>Leukemia, Prolymphocytic, B-Cell - pathology</topic><topic>Myeloid cells</topic><topic>Myeloid Cells - immunology</topic><topic>Myeloid Cells - pathology</topic><topic>myeloid effector cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lohse, Stefan</creatorcontrib><creatorcontrib>Loew, Sebastian</creatorcontrib><creatorcontrib>Kretschmer, Anna</creatorcontrib><creatorcontrib>Jansen, J. H. Marco</creatorcontrib><creatorcontrib>Meyer, Saskia</creatorcontrib><creatorcontrib>ten Broeke, Toine</creatorcontrib><creatorcontrib>Rösner, Thies</creatorcontrib><creatorcontrib>Dechant, Michael</creatorcontrib><creatorcontrib>Derer, Stefanie</creatorcontrib><creatorcontrib>Klausz, Katja</creatorcontrib><creatorcontrib>Kellner, Christian</creatorcontrib><creatorcontrib>Schwanbeck, Ralf</creatorcontrib><creatorcontrib>French, Ruth R.</creatorcontrib><creatorcontrib>Tipton, Thomas R. W.</creatorcontrib><creatorcontrib>Cragg, Mark S.</creatorcontrib><creatorcontrib>Schewe, Denis M.</creatorcontrib><creatorcontrib>Peipp, Matthias</creatorcontrib><creatorcontrib>Leusen, Jeanette H. W.</creatorcontrib><creatorcontrib>Valerius, Thomas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lohse, Stefan</au><au>Loew, Sebastian</au><au>Kretschmer, Anna</au><au>Jansen, J. H. Marco</au><au>Meyer, Saskia</au><au>ten Broeke, Toine</au><au>Rösner, Thies</au><au>Dechant, Michael</au><au>Derer, Stefanie</au><au>Klausz, Katja</au><au>Kellner, Christian</au><au>Schwanbeck, Ralf</au><au>French, Ruth R.</au><au>Tipton, Thomas R. W.</au><au>Cragg, Mark S.</au><au>Schewe, Denis M.</au><au>Peipp, Matthias</au><au>Leusen, Jeanette H. W.</au><au>Valerius, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2018-05</date><risdate>2018</risdate><volume>181</volume><issue>3</issue><spage>413</spage><epage>417</epage><pages>413-417</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>28449349</pmid><doi>10.1111/bjh.14624</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-0777-5995</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2018-05, Vol.181 (3), p.413-417 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1893551691 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | ADCC Animals antibody therapy Antibody-Dependent Cell Cytotoxicity - drug effects Antigens, CD20 - immunology Antineoplastic Agents, Immunological - immunology Antineoplastic Agents, Immunological - pharmacology CD20 CD20 antigen CHO Cells Complement System Proteins - immunology Cricetulus Cytotoxicity Hematology Humans IgA antibody Immunoglobulin A Immunoglobulin A - immunology Immunoglobulin A - pharmacology Leukemia, Prolymphocytic, B-Cell - drug therapy Leukemia, Prolymphocytic, B-Cell - immunology Leukemia, Prolymphocytic, B-Cell - pathology Myeloid cells Myeloid Cells - immunology Myeloid Cells - pathology myeloid effector cells |
| title | Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T06%3A06%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effector%20mechanisms%20of%20IgA%20antibodies%20against%20CD20%20include%20recruitment%20of%20myeloid%20cells%20for%20antibody%E2%80%90dependent%20cell%E2%80%90mediated%20cytotoxicity%20and%20complement%E2%80%90dependent%20cytotoxicity&rft.jtitle=British%20journal%20of%20haematology&rft.au=Lohse,%20Stefan&rft.date=2018-05&rft.volume=181&rft.issue=3&rft.spage=413&rft.epage=417&rft.pages=413-417&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.14624&rft_dat=%3Cproquest_cross%3E1893551691%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3884-4ddc09b5f73cf51ef0513f25d3cc06867e4a23b1d18aeb25a4950b47070e0b653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2030182528&rft_id=info:pmid/28449349&rfr_iscdi=true |